TLR4 and its downstream signaling molecules, including CD14, MyD88, and TRAF6, are up-regulated in renal tubular and renal endothelial cells in COVID-19 patients, and are closely associated with acute tubular necrosis and increased kidney injury. The gene discussed is MYD88; the disease is COVID-19.